tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SKYE Stock Latest News

SKYE Bioscience: Advancing Nimacimab Dose Expansion and Clear Phase 2b Path as Adjunct to Semaglutide Supports Buy Rating
RatingsSKYE Bioscience: Advancing Nimacimab Dose Expansion and Clear Phase 2b Path as Adjunct to Semaglutide Supports Buy Rating
7d ago
SKYE
Skye Bioscience reports Q4 EPS (36c), consensus (31c)
PremiumThe Fly
Skye Bioscience reports Q4 EPS (36c), consensus (31c)
7d ago
SKYE
SKYE Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
SKYE Upcoming Earnings Report: What to Expect?
10d ago
SKYE
Skye Bioscience: Nimacimab’s Emerging Clinical Profile and Undervalued Asymmetric Risk/Reward Support Buy Rating
PremiumRatings
Skye Bioscience: Nimacimab’s Emerging Clinical Profile and Undervalued Asymmetric Risk/Reward Support Buy Rating
1M ago
SKYE
Skye Bioscience Reports Promising Phase 2a Obesity Data
PremiumCompany Announcements
Skye Bioscience Reports Promising Phase 2a Obesity Data
1M ago
8K
SKYE
Skye Bioscience announces 52-week data from Phase 2a CBeyond study of nimacimab
PremiumThe FlySkye Bioscience announces 52-week data from Phase 2a CBeyond study of nimacimab
1M ago
SKYE
Skye Bioscience presents poster on efficacy of Nimacimab
Premium
The Fly
Skye Bioscience presents poster on efficacy of Nimacimab
2M ago
SKYE
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/14/26
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—1/14/26
2M ago
CLB
VTI
Skye Bioscience provides 2026 corporate outlook
PremiumThe Fly
Skye Bioscience provides 2026 corporate outlook
2M ago
SKYE
What Investors Can Learn from the Skye Bioscience Securities Fraud Allegations: A Risk Assessment Guide
PremiumClass Action
What Investors Can Learn from the Skye Bioscience Securities Fraud Allegations: A Risk Assessment Guide
2M ago
SKYE
VTI ETF Daily Update — 1/7/26
PremiumMarket News
VTI ETF Daily Update — 1/7/26
2M ago
RPT
VTI
Skye Bioscience: ENHANZE Partnership Unlocks Nimacimab Dosing, De-Risks Phase 2b Path and Supports Buy Rating
PremiumRatings
Skye Bioscience: ENHANZE Partnership Unlocks Nimacimab Dosing, De-Risks Phase 2b Path and Supports Buy Rating
2M ago
SKYE
Skye Bioscience, Halozyme enter collaboration, license agreement
PremiumThe FlySkye Bioscience, Halozyme enter collaboration, license agreement
2M ago
HALO
SKYE
Halozyme, Skye Bioscience announce global collaboration, license agreement
Premium
The Fly
Halozyme, Skye Bioscience announce global collaboration, license agreement
2M ago
HALO
SKYE
Skye Bioscience Collaborates with Halozyme on Nimacimab Delivery
Premium
Company Announcements
Skye Bioscience Collaborates with Halozyme on Nimacimab Delivery
3M ago
8K
SKYE
Skye Bioscience Faces Lawsuit Over Misleading Claims
PremiumClass Action
Skye Bioscience Faces Lawsuit Over Misleading Claims
4M ago
SKYE
Promising Adjunct Potential of Skye Bioscience’s Nimacimab Reinforces Buy Rating
PremiumRatings
Promising Adjunct Potential of Skye Bioscience’s Nimacimab Reinforces Buy Rating
4M ago
SKYE
Skye Bioscience Earnings Call: Mixed Signals with Promising Results
PremiumCompany Announcements
Skye Bioscience Earnings Call: Mixed Signals with Promising Results
4M ago
SKYE
Skye Bioscience Reports Promising Q3 2025 Results
PremiumCompany Announcements
Skye Bioscience Reports Promising Q3 2025 Results
4M ago
SKYE
Skye Bioscience reports Q3 EPS (32c), consensus (32c)
PremiumThe FlySkye Bioscience reports Q3 EPS (32c), consensus (32c)
4M ago
SKYE
SKYE Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SKYE Earnings this Week: How Will it Perform?
4M ago
SKYE
Skye Bioscience to present topline data from CBeyond on nimacimab
Premium
The Fly
Skye Bioscience to present topline data from CBeyond on nimacimab
4M ago
SKYE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >